Legal Challenges Facing SelectQuote Inc.
SelectQuote Inc. (NYSE: SLQT), a digital platform for insurance, is currently experiencing intense legal scrutiny following the intervention by the U.S. Department of Justice (DOJ) in a whistleblower lawsuit that alleges deceptive sales practices. This intervention has led to a notable decline of 19% in SelectQuote's stock price, a situation that has now escalated into a securities class-action lawsuit that impacts investors significantly.
Overview of the Class Action Lawsuit
The lawsuit, known as Pahlkotter v. SelectQuote Inc. et al, includes investors who bought shares of SelectQuote from September 9, 2020, to May 1, 2025. The complaint states that the company misled the market regarding its business practices and the regulatory environment in which it operates.
Nature of the Claims
Central to the allegations are claims that SelectQuote has not been forthright regarding its Medicare Advantage sales tactics. While promoting its services as providing unbiased advice to consumers, the lawsuit claims that the company has:
- Directed customers towards insurers that offer the highest commissions.
- Accepted unlawful kickbacks in exchange for favorable recommendations.
- Violated federal laws, including the False Claims Act.
DOJ's Involvement and Its Implications
The DOJ's involvement has had a profound impact, resulting in a sharp decline of nearly 20% in SelectQuote's share price in just one day. Over the last several months, the stock has plummeted more than 40%, illustrating the growing concerns among investors regarding the firm's legal troubles and potential damage to its reputation.
Repercussions for Investors
Investors are left reeling as the class-action lawsuit argues that SelectQuote's misleading public statements failed to communicate critical risks associated with its sales methods. This has led to a distorted perception of its growth potential and revenue reliability.
Ongoing Investigations into Revenue Practices
The shareholder rights firm Hagens Berman is investigating claims related to potential revenue manipulation by SelectQuote. According to Reed Kathrein, a partner at the firm, the DOJ's involvement has significantly escalated the seriousness of the situation. He stated, "What was once viewed as a routine business disagreement is now a severe federal issue. We are evaluating if SelectQuote's advertised 'unbiased' approach was simply a cover for a kickback-driven sales structure."
How to Get Involved
If you are an investor in SelectQuote and have incurred significant losses, or if you can provide relevant insights that may aid in the investigation, it is advisable to take action promptly.
Whistleblower Information
Individuals with insider knowledge regarding SelectQuote's operations are encouraged to consider their opportunities for assisting the investigation or potentially participating in the SEC Whistleblower program. This initiative allows whistleblowers who offer original information to earn rewards that could total up to 30% of any successful SEC recovery. For further inquiries, you can contact Reed Kathrein directly.
About Hagens Berman
Hagens Berman is a national law firm dedicated to the rights of plaintiffs and engaged in complex litigation that holds corporations accountable. They have helped secure more than $2.9 billion for affected parties in numerous cases. The firm focuses on supporting investors, whistleblowers, and individuals harmed by corporate misconduct.
Frequently Asked Questions
What is the SelectQuote lawsuit about?
The lawsuit involves allegations of deceptive sales practices by SelectQuote, particularly regarding Medicare Advantage plans, which misled investors.
Who can join the class-action lawsuit?
Investors who purchased SelectQuote stock between September 9, 2020, and May 1, 2025, are eligible to join the lawsuit.
How has the stock price been affected?
SelectQuote's stock has experienced a significant decline, dropping nearly 20% in a single day and more than 40% over recent months.
What should investors do now?
Investors are encouraged to assess their losses and consider joining the class-action lawsuit to seek potential recovery.
Who can provide information about illegal practices?
Whistleblowers with non-public information about SelectQuote's operations can report their findings and may qualify for rewards through the SEC Whistleblower program.
